This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Tuesday, April 12, 2016
Link To Coverage: The International Liver Congress 2016
The International Liver Congress 2016
April 13-17 in Barcelona, Spain
Official Website
Twitter Account
View all updates on Twitter: #ILC2016
Conference Updates Indexed By Pharmaceutical Company
Hepatitis C Breaking Conference Reports
Link to interim results from ongoing HCV interferon-free, ribavirin-free clinical trials presented at this months meeting with slide presentations, video highlights and commentary.
Blog: HCV New Drugs - Media Updates
Abstracts for The International Liver Congress™ 2016
Browse Abstracts
ILC 2016 Abstract ebook
No comments:
Post a Comment